omniture
海南惠普森医药生物技术有限公司 China Pharma Holdings Inc.

Latest News

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

HAIKOU, China, Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("Chi...

2021-08-05 21:00 27364
12